The Scientist

» immunotherapy and evolution

Most Recent

image: Neoantigens Enable Personalized Cancer Immunotherapy

Neoantigens Enable Personalized Cancer Immunotherapy

By | April 1, 2017

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

1 Comment

image: Infographic: Antibody Cancer Therapy

Infographic: Antibody Cancer Therapy

By | April 1, 2017

An experimental technique removes T cells that aid in vitro tumor growth.

3 Comments

image: Infographic: Targeting Cancer Antigens

Infographic: Targeting Cancer Antigens

By | April 1, 2017

Neoantigens may serve as valuable targets for new immunotherapies.

0 Comments

image: Targeting Tregs Halts Cancer’s Immune Helpers

Targeting Tregs Halts Cancer’s Immune Helpers

By | April 1, 2017

New monoclonal antibodies kill both cancer-promoting immunosuppressive cells and tumor cells in culture.

0 Comments

image: Study: Diet Contributes to Brain Size

Study: Diet Contributes to Brain Size

By | March 30, 2017

The results of a historical primate behavior analysis suggest that species with fruit-filled diets evolved larger brains.

1 Comment

image: Dinosaur Phylogenetic Tree Shake-Up

Dinosaur Phylogenetic Tree Shake-Up

By | March 24, 2017

An analysis of 74 dinosaur species leads a group of researchers to reorganize the extinct animals’ evolutionary history.

0 Comments

image: Sharks May Have Evolved from Acanthodians

Sharks May Have Evolved from Acanthodians

By | March 14, 2017

Analysis of an ancient shark fossil provides the strongest evidence to date that modern sharks derive from a class of 400 million–year-old bony fish.

0 Comments

image: Tasmanian Devil Cancer Immunotherapy

Tasmanian Devil Cancer Immunotherapy

By | March 13, 2017

Researchers in Australia claim to have successfully used immunotherapy to treat devil facial tumor disease.

0 Comments

“Buena vista” hypothesis suggests that changes in the sizes of eyes, rather than a shift from fins to limbs, led fish to transition to land more than 300 million years ago.  

1 Comment

image: Kite’s CAR T-Cell Therapy Success

Kite’s CAR T-Cell Therapy Success

By | March 1, 2017

More than one-third of lymphoma patients in a Phase 2 trial were clear of disease at six months, and no new safety concerns arose since the company’s three-month follow up.

0 Comments

Popular Now

  1. Symmetrical Eyes Indicate Dyslexia
  2. German Scientists Resign from Elsevier Journals’ Editorial Boards
  3. Germany Sees Drastic Decrease in Insects
  4. Swapping Cigarettes for Vaping
    The Scientist Swapping Cigarettes for Vaping

    New evidence suggests e-cigarettes are not without risks to human health, but can be useful in getting people to kick their smoking habit.

RayBiotech